Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future Perspectives

SIMPLE SUMMARY: The treatment landscape of advanced prostate cancer (PCa) is constantly improving with the approval of many new therapeutic options. Immunotherapy in PCa has been investigated with disappointing results. This review aims to evaluate the potential role of immunotherapy in both castrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebuzzi, Sara Elena, Rescigno, Pasquale, Catalano, Fabio, Mollica, Veronica, Vogl, Ursula Maria, Marandino, Laura, Massari, Francesco, Pereira Mestre, Ricardo, Zanardi, Elisa, Signori, Alessio, Buti, Sebastiano, Bauckneht, Matteo, Gillessen, Silke, Banna, Giuseppe Luigi, Fornarini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909751/
https://www.ncbi.nlm.nih.gov/pubmed/35267553
http://dx.doi.org/10.3390/cancers14051245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909751/
https://www.ncbi.nlm.nih.gov/pubmed/35267553
http://dx.doi.org/10.3390/cancers14051245

Ejemplares similares